Potent Dendritic Cell Vaccine Loaded with Latent Membrane Protein 2A (LMP2A)
β Scribed by Chen, Yun; Yao, Kun; Wang, Bing; Qing, Jian; Liu, Genyan
- Book ID
- 109846430
- Publisher
- Nature Publishing Group
- Year
- 2008
- Tongue
- English
- Weight
- 393 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1672-7681
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Epstein-Barr virus (EBV) is a ubiquitous virus with infections commonly resulting in a latency carrier state. Although the exact role of EBV in cancer pathogenesis remains not entirely clear, it is highly probable that it causes several lymphoid and epithelial malignancies, such as Hodg
## Abstract The latent membrane protein (LMP) 2A, one of the membraneβspanning polypeptides encoded by the EpsteinβBarr virus (EBV), has been implicated in the maintenance of viral latency and appears to function in part by inhibiting Bβcell receptor (BCR) signaling through its ITAM motifs. It has
The latent membrane proteins LMP1 and LMP2A are co-expressed in most malignancies associated with Epstein-Barr virus (EBV). In contrast with the transforming LMP1 oncoprotein, LMP2A is expressed in lymphocytes of healthy EBV carriers and considered to maintain viral latency. Critical for these LMP2A